Percutaneous RVAD with the Protek Duo for severe right ventricular primary graft dysfunction after heart transplant

J Heart Lung Transplant. 2021 Jul;40(7):580-583. doi: 10.1016/j.healun.2021.03.016. Epub 2021 Mar 25.

Abstract

Right ventricular primary graft dysfunction after heart transplant is a serious life-threatening condition. The severe form, refractory to maximal medical therapy, has traditionally required temporary mechanical support through veno-arterial extracorporeal membrane oxygenation or central right ventricular support. The Protek Duo is a dual lumen cannula recently introduced in the market, which allows for the institution of a percutaneous right ventricular support. We present the first promising case series of the use of this novel support in patients with right ventricular primary graft dysfunction after heart transplant.

Publication types

  • Case Reports

MeSH terms

  • Cardiac Catheterization / instrumentation*
  • Female
  • Heart Failure / surgery*
  • Heart Transplantation / adverse effects*
  • Heart Ventricles / physiopathology*
  • Heart-Assist Devices*
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications / etiology
  • Postoperative Complications / physiopathology
  • Postoperative Complications / therapy
  • Primary Graft Dysfunction / etiology
  • Primary Graft Dysfunction / physiopathology
  • Primary Graft Dysfunction / therapy*
  • Ventricular Dysfunction, Right / etiology
  • Ventricular Dysfunction, Right / physiopathology
  • Ventricular Dysfunction, Right / therapy*